Clinical Trials

Dr. Kanis is active in enrolling patients on clinical trials if they are eligible. 

Currently available trials include:

  • GOG 263: Randomized Phase III Clinical Trial of Adjuvant Radiation vs Chemoradiation In Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy.

  • NRG-GY018: A Phase III Randomized, Placebo-Controlled Study Of Pembrolizumab (MK-3475, NSC #776864) In Addition To Paclitaxel And Carboplatin For Measurable Stae III Or IVA, Stage IVB Or Reccurent Endometrial Cancer.

  • NRG-GY019 – A Randomized Phase III,Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum.

  • A221602: Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy.